Differences Between Trial Populations and Approved Label Populations of New Drugs in the United States and Europe (2012 to 2023): A Cross-Sectional Study

Program On Regulation, Therapeutics, And Law (PORTAL)
Division of Pharmacoepidemiology and Pharmacoeconomics
Brigham and Women's Hospital • Harvard Medical School
41 Avenue Louis Pasteur, Suite 0B17, Boston, MA 02115